<DOC>
	<DOCNO>NCT02181816</DOCNO>
	<brief_summary>The purpose survey evaluate safety efficacy long-term use azilsartan/amlodipine combination tablet LD &amp; HD ( Zacras Combination Tablets LD &amp; HD ) hypertensive patient daily medical practice .</brief_summary>
	<brief_title>Azilsartan/Amlodipine Combination Tablets LD &amp; HD Specified Drug-use Survey `` Long-term Use Survey ''</brief_title>
	<detailed_description>This survey design evaluate safety efficacy long-term use azilsartan/amlodipine combination tablet LD &amp; HD ( Zacras Combination Tablets LD &amp; HD ) hypertensive patient daily medical practice . For adult , one azilsartan/amlodipine combination tablet ( 20 mg/2.5 mg [ LD tablets ] 20 mg/5 mg [ HD tablet ] azilsartan/amlodipine ) administer orally daily . Azilsartan/amlodipine combination tablet use first-line drug treatment hypertension .</detailed_description>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Hypertensive patient Hypertensive patient meet following condition , [ 1 ] [ 3 ] , exclude survey : 1 . Patients history hypersensitivity ingredient Zacras Combination Tablets dihydropyridine drug 2 . Patients pregnant possibility pregnant 3 . Diabetic patient take aliskiren fumarate ( exclude markedly poor blood pressure control even antihypertensive treatment )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Pharmacological therapy</keyword>
</DOC>